demographic tsunami

The world is ageing faster than ever: by 2050, 2.1 billion people will be over 60, and the 80+ cohort—the heaviest healthcare users—will triple to 426 million. Chronic disease prevalence among this population is driving an unprecedented market opportunity: the chronic care sector alone is projected to grow from $9.74B in 2025 to $38B by 2034 (CAGR 16.34%). Success, however, depends on tackling affordability, operational resilience, and multimorbidity-focused R&D.

Strategic Imperatives for Pharma CXOs:

• R&D Re-orientation: Develop multi-target, geriatric-optimized therapies that address polypharmacy and functional independence, aligning with Value-Based Care (VBC) models.
• Fiscal Prioritization: Accelerate adoption of generics, biosimilars, and Digital Therapeutics (DTx) to sustainably scale care delivery.
• Operational Resilience: Institutionalize dual-sourcing, nearshoring, and leverage AI/Digital Twins to protect supply chains from $25B annual disruption risks.

Emerging Market Focus – India & LMICs:

With two-thirds of the global elderly population residing in LMICs by 2050, India represents a critical growth engine. The geriatric healthcare market is projected to reach $97.3B by 2033, demanding digital-first, low-barrier solutions for Tier 2/3 cities, integrated with homecare and Remote Patient Monitoring (RPM).

The demographic tsunami is here. Will your company lead the $38B growth wave—or be swept aside? 

Download your copy today to know the answer!!